SitemapLink DividerContact Us

CIPR Awards PR Week Awards - Finalist 2008 Sabre Awards - Best UK and Ireland PR Campaign 2007

Understanding business issues from every angle

Pharma & Biotech

Exceptional track record – IPOs and Fundraisings.

View CDR's exceptional track record in M&A.

abingworth.jpg

£300 million ABV V fundraising (2007)

algeta.jpg

€23 million Private placement (2005) €30 million IPO (OSE - 2007)

arpida.jpg

€63 million IPO (SWX - 2005)

biofusion.jpg

£8.2 million IPO (AIM - 2005) £7.75 million placing (AIM - 2006)

chi_med.jpg

£40 million IPO (AIM - 2006)

exonhit.jpg

€7.5 million IPO (Alternext - 2005) €13 million secondary offering

inion.jpg

£35 million IPO (LSE - 2004)

metabolic.jpg

€60 million IPO (Euronext Paris - 2007)

phs.jpg

£880 million IPO (LSE/Moscow 2007)

psivida.jpg

$15 million PIPE (2005)

santhera.jpg

CHF88.5 million IPO (SWX - 2006)

thrombogenics.jpg

€35 million IPO (Euronext Belgium - 2006) €23.9 million secondary offering

topotarget.jpg

€30 million IPO (CSE - 2005)

summit.jpg

£10.4 million placing (AIM - 2006)

zentiva.jpg

$200 million IPO (Prague/LSE - 2004)